封面
市場調查報告書
商品編碼
1716869

海洋生物技術市場按產品類型、來源、技術、應用、最終用戶分類-2025-2030 年全球預測

Marine Biotechnology Market by Product Type, Source, Technology, Application, End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計海洋生物技術市場在 2024 年的價值將達到 82.8 億美元,2025 年將達到 88.8 億美元,到 2030 年預計將達到 127.9 億美元,複合年成長率為 7.51%。

主要市場統計數據
基準年2024年 82.8億美元
預計2025年 88.8億美元
預測年份 2030 127.9億美元
複合年成長率(%) 7.51%

海洋生物技術處於科學創新的前沿,將海洋的奇妙與先進技術的突破相結合,以解決世界上一些最緊迫的挑戰。過去幾年,行業專家見證了由環境問題、技術進步和研發投資激增等因素共同推動的快速發展。這種轉變不僅為藥物研發和健康應用開闢了新途徑,也為針對環境保護、能源生產和高效食品供應系統的永續工業解決方案開闢了新途徑。

該行業的成長與世界對永續實踐的重新關注密切相關。相關人員已經認知到海洋生態系統具有提供尚未開發的生物活性化合物和生物材料庫的巨大潛力。隨著政府和私人投資者投入大量資源探索這些海洋資源,該領域的多學科專家之間的合作正在加強,從微生物學家和化學工程師到資料科學家和政​​策制定者。這種人才的融合產生了強大的協同效應,不斷創造有希望的機會和創新產品。

摘要旨在強調影響市場發展的動態變化,強調關鍵細分考慮因素和區域趨勢,並為尋求獲得競爭優勢的行業領導者提供重要建議。本概述採用綜合辦法,既是介紹,也是探索海洋生物技術新途徑的號召。

改變海洋生物技術市場

近年來,海洋生物技術領域的競爭格局正在發生新的變化。分子生物學、數據分析和水產養殖方法的進步促進了新經營模式和研究範式的出現。目前,先驅研究主要集中於基因組學和非培養技術,從而發現具有在各個工業領域應用潛力的獨特海洋化合物。快速的技術進步不僅擴大了生物活性水產品的範圍,而且重塑了傳統的供應鏈和生產流程。

推動這一演變的是從傳統方法到創新技術方法的轉變,其中結合了獨立於培養的技術和複雜的分離培養方法。這種適應性將使我們能夠更精確地表徵海洋生物,從而實現工業規模的生產和對以前無法接近的微生物群落的詳細研究。採用新工作流程的靈活性使市場參與者能夠最大限度地降低生產成本,同時提高產品的特殊性和功效,從而使海洋生物技術對投資者和開發商越來越有吸引力。

同時,人們對環境永續性的認知不斷提高,以及綠色解決方案的經濟要求正在重塑戰略投資。該領域的轉型特點是將科學研究與市場需求的理解進行深思熟慮的結合,將海洋生物技術定位為突破性創新的關鍵培養箱。隨著全球對永續、增進健康的產品的需求激發研究工作和策略夥伴關係,未來的發展預計將進一步突破界限。這些變革性轉變的鞏固標誌著產業內部正朝著更有效率、創新和永續的流程邁進。

海洋生物技術市場的關鍵細分洞察

在分析海洋生物技術市場時,詳細的細分見解提供了不斷變化的趨勢和新興機會的清晰圖像。當根據產品類型考察市場時,生物活性化合物和生物材料受到了廣泛關注。這種雙重關注使公司能夠開發廣泛的產品,從旨在實現高功效的藥物化合物到滿足技術工業要求的專用生醫材料。同樣,基於源的分割揭示了涵蓋珊瑚和海綿、海洋藻類、海洋真菌和海洋病毒的廣泛研究。每一種天然來源都對生物活性特徵有著獨特的貢獻,提供了廣泛應用所必需的獨特生化特性。

基於技術的進一步分類強調了與微生物分離和培養同時進行的培養獨立技術的重要性。這種雙重觀點確保調查方法足夠強大和靈活,以捕捉和培育海洋生物的複雜性。深入研究基於應用的細分,市場研究涉及水產養殖和漁業、生質燃料、藥物發現、環境和人類健康、食品供應以及工業產品和流程等領域。如此廣泛的應用凸顯了該行業影響現代工業和生活方式許多方面的能力。

此外,根據最終用戶的細分,市場參與分為化學、化妝品、能源、食品工業以及醫療和製藥領域。這種分層細分方法是了解如何定位和服務不同客戶群的關鍵。結構化細分提供了全面的視圖,可協助相關人員調整其產品和策略,從而推動每個特定領域的成長和創新。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 提高人們對海洋生物多樣性和保育的認知
      • 消費者對生物來源的天然成分的需求不斷增加
      • 製藥業對海洋衍生化合物的興趣日益濃厚
    • 限制因素
      • 研發高成本
    • 機會
      • 增加對海洋基因組學的資助,用於發現新型態酶
      • 對源自海藻的環保生質燃料的需求不斷增加
    • 任務
      • 平衡海洋生物技術的永續性和商業性利益
  • 市場區隔分析
    • 產品類型:具有抗菌和抗癌特性的生物活性化合物的生長偏好
    • 應用:海洋生物技術在水產養殖和漁業的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 海洋生物技術市場(依產品類型)

  • 生物活性化合物
  • 生物材料

7. 海洋生物技術市場(依來源)

  • 珊瑚和海綿
  • 海藻
  • 海洋真菌
  • 海洋病毒

8. 海洋生物技術市場(依技術)

  • 獨立於文化的技術
  • 微生物分離與培養

第9章海洋生物技術市場(按應用)

  • 水產養殖及漁業
  • 生質燃料
  • 藥物研發
  • 環境與人類健康
  • 糧食供應
  • 工業產品和工藝

第 10 章 海洋生物技術市場(依最終使用者)

  • 化學品
  • 化妝品
  • 能源
  • 食品工業
  • 醫療和製藥

11.美洲海洋生物技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12.亞太海洋生物技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13.歐洲、中東和非洲海洋生物技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Aker BioMarine ASA
  • BASF SE
  • Benchmark Holdings plc
  • Biolchim Group by JM Huber Corporation
  • BioLume, Inc.
  • BlueBioTech GmbH
  • Cellana Inc.
  • Corbion NV
  • DSM-Firmenich AG
  • Earthrise Nutritionals LLC
  • GeoMarine Biotechnologies(P)LTD
  • GlycoMar Ltd.
  • Marine Biopolymers Ltd.
  • Marinova Pty Ltd
  • Marshall Marine Products
  • Nofima
  • oceanBASIS GmbH
  • Pharma Mar, SA
  • PROLUME, LTD
  • Seppic SA
  • The GELITA Group
  • Veramaris VOF
  • Xanthella Ltd.
  • ZIVO Bioscience, Inc.
Product Code: MRR-02026C4C9A70

The Marine Biotechnology Market was valued at USD 8.28 billion in 2024 and is projected to grow to USD 8.88 billion in 2025, with a CAGR of 7.51%, reaching USD 12.79 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 8.28 billion
Estimated Year [2025] USD 8.88 billion
Forecast Year [2030] USD 12.79 billion
CAGR (%) 7.51%

Marine Biotechnology stands at the frontier of scientific innovation, blending the mysteries of the sea with advanced technological breakthroughs to address some of the world's most pressing challenges. In recent years, industry experts have witnessed a rapid evolution driven by a combination of environmental imperatives, technological advancements, and a surge in investment in research and development. This transformation has opened new pathways not only for drug discovery and health applications but also for sustainable industrial solutions that target environmental conservation, energy production, and efficient food supply systems.

The sector's growth is deeply intertwined with a renewed global focus on sustainable practices. Stakeholders are recognizing the immense potential of the marine ecosystem, which offers an untapped reservoir of bioactive compounds and biomaterials. As governments and private investors channel significant resources into exploring these oceanic resources, the field has experienced increased collaboration between multidisciplinary experts, ranging from microbiologists and chemical engineers to data scientists and policy makers. This confluence of talents is creating powerful synergies that continue to unveil promising opportunities and innovative products.

This summary is designed to provide clarity on the dynamic changes shaping the market's evolution, highlight key segmentation insights and regional trends, and offer imperative recommendations for industry leaders looking to seize competitive advantages. With a comprehensive approach that bridges scientific insight and market analysis, this overview serves as both an introduction and a call to explore novel avenues in marine biotechnology.

Transformative Shifts in the Marine Biotechnology Landscape

Recent years have seen transformative shifts that redefine the competitive landscape in marine biotechnology. A confluence of advancements in molecular biology, data analytics, and cultivation methods has catalyzed the emergence of new business models and research paradigms. Pioneering studies now focus on genome analysis and culture-independent techniques leading to the discovery of unique marine compounds with applications across various industries. Rapid technological progress has not only widened the scope of biologically active marine products, but it has also restructured traditional supply chains and manufacturing processes.

A driving force behind this evolution is the shift from classical methodologies to innovative technical approaches that incorporate both culture-independent techniques and refined isolation and cultivation methods. Such adaptations allow for more precise characterization of marine organisms, enabling industrial-scale production and in-depth exploration of previously inaccessible microbial colonies. The agility in adopting new workflows has allowed market players to minimize production costs while enhancing product specificity and efficacy, making marine biotechnology an increasingly attractive prospect for investors and developers alike.

Simultaneously, heightened awareness of environmental sustainability and the economic imperatives of green solutions have reshaped strategic investments. This sector's transition is marked by a thoughtful integration of scientific research with an understanding of market needs, positioning marine biotechnology as a crucial incubator for breakthrough innovations. Future developments promise to push the envelope even further, as global demands for sustainable and health-enhancing products galvanize research efforts and strategic partnerships. The integration of these transformative shifts underlines a vibrant movement toward more efficient, innovative, and sustainable processes within the industry.

Key Segmentation Insights in Marine Biotechnology Markets

In analyzing the marine biotechnology market, detailed segmentation insights provide a clear picture of evolving trends and emerging opportunities. When examining the market based on product type, significant attention is drawn to bioactive compounds and biomaterials. This dual focus allows companies to develop products that range from pharmaceutical compounds designed for high efficacy to specialized biomaterials that meet technical industrial requirements. Similarly, the segmentation based on source reveals an expansive study that spans corals and sponges, marine algae, marine fungi, and marine viruses. Each of these natural sources contributes uniquely to the bioactive profile and offers distinct biochemical properties essential for a wide array of applications.

Further segmentation based on technology highlights the importance of culture-independent techniques alongside the isolation and cultivation of microorganisms. This dual perspective ensures that research methodologies are robust and versatile enough to capture and nurture the complexity of marine organisms. Delving into application-based segmentation, the market is studied across domains such as aquaculture and fishery, biofuels, drug discovery, environmental health and human health, food supply, and industrial products and processes. Such a varied application landscape underscores the sector's capacity to influence multiple facets of contemporary industry and lifestyle.

Moreover, the segmentation based on end-user categorizes market engagement across the chemical, cosmetics, energy, food industry, and medical and pharmaceutical fields. This layered segmentation approach is critical in understanding how diverse customer bases are targeted and served. The structured breakdown offers a comprehensive view that helps stakeholders tailor products and strategies, thereby fostering growth and innovation across each specific segment.

Based on Product Type, market is studied across Bioactive Compounds and Biomaterials.

Based on Source, market is studied across Corals & Sponges, Marine Algae, Marine Fungi, and Marine Viruses.

Based on Technology, market is studied across Culture-Independent Techniques and Isolation & Cultivation of Microorganisms.

Based on Application, market is studied across Aquaculture & Fishery, Biofuels, Drug Discovery, Environmental Health & Human Health, Food supply, and Industrial Products & Processes.

Based on End-User, market is studied across Chemical, Cosmetics, Energy, Food Industry, and Medical & Pharmaceutical.

Key Regional Insights Across Global Markets

Geographic analysis plays a pivotal role in understanding the global proliferation of marine biotechnology innovations. The Americas serve as a major hub of research, development, and commercialization, underpinned by robust governmental support and a strong foundation in biotechnological research. The region boasts a dynamic network of academic and private sector collaborators, which fosters a fertile ground for pioneering research and breakthrough compounds.

In Europe, the Middle East and Africa cluster, a tapestry of diverse regulatory environments and innovative research centers, significantly contributes to shaping market dynamics. This geographical segment is characterized by both long-established biotechnological institutes and emerging players who emphasize sustainable practices and environmental conservation. The collective expertise from these regions fuels advances in technology, thereby ensuring that marine biotechnology continues to evolve amidst challenging and variable market conditions.

The Asia-Pacific region also stands out as a rapidly growing market, driven by expansive economic growth and increasing investments in biotechnology infrastructure. This region's cultural emphasis on technological innovation and integration with traditional practices elevates its market stature, positioning it as a key player in leveraging marine resources. With a combination of academic excellence and strong industrial output, Asia-Pacific is charting a course toward unprecedented levels of market penetration. The comparative regional insights help clarify how diverse markets are not only aligned in seeking sustainable solutions but are also continuously influencing the global landscape of marine biotechnology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Market Innovation

A close examination of the major industry players reveals a landscape that is both competitive and collaborative. Prominent companies that are driving innovation in marine biotechnology include Aker BioMarine ASA, BASF SE, and Benchmark Holdings plc. These entities, along with others such as Biolchim Group by J.M. Huber Corporation and BioLume, Inc., are at the forefront of translating research into commercially viable solutions. Other innovators like BlueBioTech GmbH, Cellana Inc., and Corbion N.V. bolster the competitive edge of the sector by continuously introducing technologies and practices that push conventional boundaries.

Further stirring the industry are firms such as DSM-Firmenich AG, Earthrise Nutritionals LLC, and GeoMarine Biotechnologies (P) LTD, whose emphasis on integrated research and sustainable development has reinforced the role of marine biotechnology in modern industry. Companies like GlycoMar Ltd., Marine Biopolymers Ltd., and Marinova Pty Ltd. also contribute significantly with breakthrough innovations that redefine product reliability and performance. Marshall Marine Products, Nofima, and oceanBASIS GmbH add to this dynamic mix by steering innovation through collaborative research and strategic partnerships.

The landscape is also enriched by the contributions of Pharma Mar, S.A., PROLUME, LTD, Seppic S.A., and The GELITA Group, each of which has carved out unique niches across product and application segments. Veramaris V.O.F., Xanthella Ltd., and ZIVO Bioscience, Inc. further round out the profile of companies that are not only responding to current market demands but are also actively shaping the direction of future growth. The robust involvement of these companies demonstrates a comprehensive commitment to advancing sustainable and high-impact marine technologies.

The report delves into recent significant developments in the Marine Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, BASF SE, Benchmark Holdings plc, Biolchim Group by J.M. Huber Corporation, BioLume, Inc., BlueBioTech GmbH, Cellana Inc., Corbion N.V., DSM-Firmenich AG, Earthrise Nutritionals LLC, GeoMarine Biotechnologies (P) LTD, GlycoMar Ltd., Marine Biopolymers Ltd., Marinova Pty Ltd, Marshall Marine Products, Nofima, oceanBASIS GmbH, Pharma Mar, S.A., PROLUME, LTD, Seppic S.A., The GELITA Group, Veramaris V.O.F., Xanthella Ltd., and ZIVO Bioscience, Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are urged to pursue an agile yet strategic approach to meet the evolving challenges and opportunities in marine biotechnology. First, it is imperative to invest in state-of-the-art research infrastructure that leverages both culture-independent techniques and advanced isolation methodologies to fully utilize the genetic and biochemical diversity present in marine organisms. Concurrently, there should be an emphasis on developing integrated data analytics systems to generate actionable insights that blend market expectations with scientific breakthroughs.

Leaders must consider forging collaborative partnerships with academic institutions, research centers, and cross-sector specialists to accelerate product innovation and facilitate technology transfer. Engaging in public-private partnerships can further bolster the developmental ecosystem, ensuring that innovative solutions are not only financially viable but also meet stringent regulatory and sustainability benchmarks. Moreover, companies should align their strategies with the growing global emphasis on green technologies, promotion of environmental health, and sustainable manufacturing practices.

It is also recommended to embark on pilot projects that demonstrate the commercial viability of emerging marine technologies in specific sectors such as drug discovery, biofuels, and industrial processing. These initiatives serve as proof-of-concept and offer a blueprint for scaling up operations while mitigating risks. Furthermore, leaders should continuously upgrade their existing capabilities by adopting a robust risk management framework to navigate regulatory challenges and market volatilities. A strategic focus on customer-centric innovation will help align technological development with evolving consumer needs while securing competitive advantages in a dynamic global marketplace.

Conclusion: Navigating a Transformative Future

The dynamic realm of marine biotechnology is characterized by innovation, sustainability, and a compelling blend of traditional knowledge with modern science. This executive summary has provided a detailed overview of the transformative shifts influencing the industry, underscoring the importance of looking at diverse segmentation insights and regional dynamics. The analysis highlighted how subdivisions by product type, source, technology, application, and end-user collectively paint a picture of a versatile and rapidly evolving sector.

Moreover, regional insights reveal that each market, whether in the Americas, Europe, Middle East and Africa, or Asia-Pacific, brings its own unique strengths and challenges. This geographic diversity underlines the importance of tailored approaches that respect local market environments while harnessing global technological advancements. Furthermore, an in-depth review of key companies illustrates a competitive yet cooperative sector where leaders are not only challenging traditional paradigms but are setting new benchmarks for innovation and sustainability.

In conclusion, a holistic strategy that integrates advanced research, strategic collaborations, and a commitment to sustainable practices is vital for unlocking the full potential of marine biotechnology. While the journey ahead promises significant rewards, investment in talent, technology, and a resilient supply chain will be key for achieving enduring success in this transformative industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness about marine biodiversity and conservation
      • 5.1.1.2. Growing consumer demand for natural ingredients sourced from marine life
      • 5.1.1.3. Increasing pharmaceutical interest in marine-derived compounds
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing funding in marine genomics for the discovery of novel enzymes
      • 5.1.3.2. Rising demand for eco-friendly biofuels derived from marine algae
    • 5.1.4. Challenges
      • 5.1.4.1. Balancing sustainability and commercial interests in marine biotechnology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Proliferating preference for bioactive compounds owing to their antibacterial and anticancer properties
    • 5.2.2. Application: Rising significance of marine biotechnology in aquaculture and fishery sector
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Marine Biotechnology Market, by Product Type

  • 6.1. Introduction
  • 6.2. Bioactive Compounds
  • 6.3. Biomaterials

7. Marine Biotechnology Market, by Source

  • 7.1. Introduction
  • 7.2. Corals & Sponges
  • 7.3. Marine Algae
  • 7.4. Marine Fungi
  • 7.5. Marine Viruses

8. Marine Biotechnology Market, by Technology

  • 8.1. Introduction
  • 8.2. Culture-Independent Techniques
  • 8.3. Isolation & Cultivation of Microorganisms

9. Marine Biotechnology Market, by Application

  • 9.1. Introduction
  • 9.2. Aquaculture & Fishery
  • 9.3. Biofuels
  • 9.4. Drug Discovery
  • 9.5. Environmental Health & Human Health
  • 9.6. Food supply
  • 9.7. Industrial Products & Processes

10. Marine Biotechnology Market, by End-User

  • 10.1. Introduction
  • 10.2. Chemical
  • 10.3. Cosmetics
  • 10.4. Energy
  • 10.5. Food Industry
  • 10.6. Medical & Pharmaceutical

11. Americas Marine Biotechnology Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Marine Biotechnology Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Marine Biotechnology Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Dominican Republic launches first blue biotechnology company
    • 14.3.2. MiAlgae secured GBP 14 million to expand its operations for sustainable Omega-3s
    • 14.3.3. Regenics raised NOK 20.4 million to fund trials for Collex
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aker BioMarine ASA
  • 2. BASF SE
  • 3. Benchmark Holdings plc
  • 4. Biolchim Group by J.M. Huber Corporation
  • 5. BioLume, Inc.
  • 6. BlueBioTech GmbH
  • 7. Cellana Inc.
  • 8. Corbion N.V.
  • 9. DSM-Firmenich AG
  • 10. Earthrise Nutritionals LLC
  • 11. GeoMarine Biotechnologies (P) LTD
  • 12. GlycoMar Ltd.
  • 13. Marine Biopolymers Ltd.
  • 14. Marinova Pty Ltd
  • 15. Marshall Marine Products
  • 16. Nofima
  • 17. oceanBASIS GmbH
  • 18. Pharma Mar, S.A.
  • 19. PROLUME, LTD
  • 20. Seppic S.A.
  • 21. The GELITA Group
  • 22. Veramaris V.O.F.
  • 23. Xanthella Ltd.
  • 24. ZIVO Bioscience, Inc.

LIST OF FIGURES

  • FIGURE 1. MARINE BIOTECHNOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. MARINE BIOTECHNOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. MARINE BIOTECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. MARINE BIOTECHNOLOGY MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. MARINE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. MARINE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MARINE BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MARINE BIOTECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOACTIVE COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CORALS & SPONGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CULTURE-INDEPENDENT TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ISOLATION & CULTIVATION OF MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY AQUACULTURE & FISHERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL HEALTH & HUMAN HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY FOOD SUPPLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PRODUCTS & PROCESSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ENERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MEDICAL & PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. MARINE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 241. MARINE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024